1. Home
  2. CIX vs CGEN Comparison

CIX vs CGEN Comparison

Compare CIX & CGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CompX International Inc.

CIX

CompX International Inc.

N/A

Current Price

$23.29

Market Cap

291.7M

ML Signal

N/A

Logo Compugen Ltd.

CGEN

Compugen Ltd.

HOLD

Current Price

$2.71

Market Cap

270.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CIX
CGEN
Founded
1993
1993
Country
United States
Israel
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
291.7M
270.4M
IPO Year
1997
2001

Fundamental Metrics

Financial Performance
Metric
CIX
CGEN
Price
$23.29
$2.71
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$5.00
AVG Volume (30 Days)
1.7K
567.7K
Earning Date
05-05-2026
05-18-2026
Dividend Yield
9.48%
N/A
EPS Growth
17.04
N/A
EPS
0.48
N/A
Revenue
$158,285,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$75.09
P/E Ratio
$48.14
N/A
Revenue Growth
8.46
N/A
52 Week Low
$20.29
$1.30
52 Week High
$32.30
$3.24

Technical Indicators

Market Signals
Indicator
CIX
CGEN
Relative Strength Index (RSI) 49.05 49.11
Support Level $22.86 $2.54
Resistance Level $23.36 $3.24
Average True Range (ATR) 0.47 0.17
MACD -0.07 -0.03
Stochastic Oscillator 35.40 29.17

Price Performance

Historical Comparison
CIX
CGEN

About CIX CompX International Inc.

Compx International Inc is a manufacturer of security products. Its security products are used in recreational transportation, postal, office & institutional furniture, cabinetry, tool storage, healthcare, and a variety of other industries. Also, it is engaged in the manufacturing of stainless steel exhaust systems, gauges, throttle controls, and trim tabs for the recreational marine industry. The company's reportable operating segment includes Security Products and Marine Components. It generates maximum revenue from the Security Products segment, which manufactures mechanical and electrical cabinet locks and other locking mechanisms. Geographically, the company generates maximum revenue from the United States, followed by Canada, Mexico, and other markets.

About CGEN Compugen Ltd.

Compugen Ltd is a clinical-stage therapeutic discovery and development company utilizing Unigen, its AI/ML-powered computational discovery capabilities, to identify novel drug targets and new biological pathways to develop therapeutics in the field of cancer immunotherapy. Its immuno-oncology pipeline consists of four clinical-stage programs: COM701, COM902, rilvegostomig, and GS-0321 (previously COM503), targeting immune checkpoints the company discovered computationally. The company's revenues are generated mainly from collaborative and license agreements. Geographically, it generates maximum revenue from the United Kingdom, and the rest from the United States.

Share on Social Networks: